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Abstract 
 In connection with the intensive investigation of proteases, several methods have been 
developed for analysis of the substrate specificity. Due to the great number of proteases and 
the expected target molecules to be analyzed, time- and cost-efficient high-throughput 
screening (HTS) methods are preferred. Here we describe the development and application of 
a separation-based HTS-compatible fluorescent protease assay, which is based on the use of 
recombinant fusion proteins as substrates of proteases. 
 The protein substrates used in this assay consists of N-terminal (hexahistidine and 
maltose binding protein) fusion tags, cleavage sequences of the tobacco etch virus (TEV) and 
HIV-1 proteases, and a C-terminal fluorescent protein (mApple or mTurquoise2). The assay is 
based on the fluorimetric detection of the fluorescent proteins, which are released from the 
magnetic bead-attached substrates by the proteolytic cleavage. The protease assay has been 
applied for activity measurements of TEV and HIV-1 proteases to test the suitability of the 
system for enzyme kinetic measurements, inhibition studies, and determination of pH 
optimum. We also found that denatured fluorescent proteins can be renatured after SDS-
PAGE of denaturing conditions, but showed differences in their renaturation abilities. After 
in-gel renaturation both substrates and cleavage products can be identified by in-gel UV 
detection.  
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1. Introduction 
 
 Due to their essential role in numerous biological processes, proteases are claimed to 
be one of the most important groups among known enzyme families. Proteases are involved in 
many biological pathways; their malfunctions can be responsible for many degenerative 
disorders, cancer, inflammations, etc. On the other hand, proteases are important drug targets 
due to their central role in the life-cycle of different bacteria, viruses, and other parasites. In 
humans, 5-10% of drug targets show protease activity, and the search for new molecules to 
target proteases is still highly important both in academic and industrial research (Choe et al., 
2006; Kostallas et al., 2011; Zhang et al., 2012).  
 In connection with the intensive investigation of proteases, several methods have been 
developed for the analysis of their substrate specificity. Due to the great number of the 
proteases and the expected target molecules to be analyzed, time- and cost efficient high-
throughput screening (HTS) methods are preferred. According to Zhang (2012), HTS-
protease assays can be divided into two major groups: homogenous and separation-based 
assays.  
 In the case of homogenous assays, it is not required for the detection to separate the 
products and/or the substrates present in the reaction mixture. Fluorescent detection-based 
assays are highly preferred due to their high sensitivity that allows detection in a dense, low 
volume format, which is especially important in HTS. The most widely utilized fluorescence-
based approaches include assays based on (i) chemically quenched dyes for example in the 
assay developed by Hassiepen et al. (2007) for deubiquitinating proteases; (ii) fluorescence 
resonance energy transfer (FRET), of which the principles were firstly described by 
Matayoshi et al. (1990) on HIV PR and it has become widely utilized and also further 
improved for example by Branchini et al. (2011); (iii) dual-label quenched pairs such as the 
one developed in our laboratory by Bagossi et al. (2004); or (iv) fluorescence polarization for 
example in case of the assay designed by Levine et al. (1997) for human 
cytomegalovirus protease.  
 On the other hand, separation-based assays offer another excellent way for 
investigating protease activity. In these approaches products and/or substrates are isolated 
from the reaction mixture mainly by liquid chromatography and analyzed independently (e.g.: 
by mass spectrometry). This assay type utilizing reversed-phase high-performance liquid 
chromatography (RP-HPLC) is also commonly applied in our laboratory as described by 
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Tözsér et al. (1991) or Fehér et al. (2006). A great advantage of these assay types is that they 
allow kinetic reading of the enzymatic reactions, although instrumentation requirements of 
these approaches are relatively high. 
 All of these approaches are excellently engineered and can be well-applied in several 
cases, although each of them has its own limitation. Chemically quenched dye-based assays 
can monitor the changes in substrate sequence only on the amino (N) side of the scissile bond, 
and cannot be applied for proteases that have strict requirements in the carboxyl (C) side of 
the cleavage site. FRET-based approaches require large percent of substrate turnover for 
reliable readouts, while assays using dual-label quenched pairs often limited by high 
background signals due to the improper separation of the fluorescents spectra. The 
fluorescence polarization assays have high sensitivity for the changes of the fluorescent 
signal, however, outside a moderate range the signal does not correlate linearly with product 
concentration. Moreover, in several assay formats the possibility of getting false positive 
results is relatively high, due to compound aggregation, enzyme degradation, impurities, or 
chemical reactivity, especially in the case of cysteine proteases, where thiol/thiolate group 
causes high-reactivity (Jadhav et al., 2010; Zhang et al., 2012).  
In addition to the widely utilized short peptide-based substrates or small molecule 
fluorescent probes, recombinant fusion protein substrates have been also successfully applied 
in several protease assay formats (Patel et al., 2001; Chaparro-Riggers et al., 2005; Askin 
et al., 2011; Branchini et al., 2011; Zhou et al., 2014). Moreover, fluorescent protein (FP) 
containing fusion protein substrates offer highly sensitive, cost-efficient, and stable tools, 
which can be easily adapted for the detection of site-specific protease cleavage (Patel et al., 
2001; Chaparro-Riggers et al., 2005; Aoki et al., 2008; Askin et al., 2011; Branchini et 
al., 2011). Some of these assays are also compatible with HTS formats (Chaparro-Riggers et 
al., 2005; Askin et al., 2011), and some also allow the determination of cleavage kinetics 
(Chaparro-Riggers et al., 2005).  
All of these approaches comprise excellent solutions for studying protease specificity, 
however, considering all of the listed aspects the development of assay formats that integrate 
most of the advantages of these platforms and may offer new ones in an improved format is 
still on demand. 
 Here we report the development and application of a separation-based, HTS-
compatible, in vitro fluorescent proteolytic assay system, which is based on the use of 
recombinant fusion protein substrates. Substrates tagged with mApple or mTurquoise2 
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fluorescent proteins have been tested for activity measurements of the human 
immunodeficiency virus type 1 protease (HIV-1 PR) and the tobacco etch virus protease 
(TEV PR). The designed system was applied to determine kinetic parameters of the studied 
enzymes, and to test the inhibitory effect of the protease inhibitor amprenavir on HIV-1 PR 
and the pH dependence of TEV PR activity. Besides measuring the fluorescence of the 
supernatants (due to the release of fluorescent cleavage products from the magnetic bead-
attached substrates) by a fluorimeter, the substrates and cleavage products were also analyzed 
by polyacrylamide gel electrophoresis in the presence or absence of denaturing conditions. 
We found that removal of SDS from the gel enables the system for fluorescent in-gel 
detection of the proteins together with their molecular weight-based identification. The 
recombinant protein substrate system described here is suitable to generate substrate libraries 
or insert wide variety of sequences into the substrates to study several types of proteases.  
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2. Materials and methods 
 
 All materials were purchased from Sigma-Aldrich (St Louis, MO, USA) unless 
otherwise indicated. 
 Oligonucleotide primer sequences are also available in the public oligonucleotide 
database of Laboratory of Retroviral Biochemistry (http://lrb.med.unideb.hu/research/oligos). 
 
2.1 Expression vectors 
 pDest-His6-MBP-mApple and pDest-His6-MBP-mTurquoise2 plasmids were prepared 
by Gateway Cloning Technology (Thermo Fischer Scientific, Invitrogen) based on Tropea et 
al. (2007). The linear DNA sequences to be transferred via pDON221 donor vector into 
pDEST-His6-MBP (Tropea et al., 2007) were amplified by a two-step PCR reaction. 
pDON221 and pDEST-His6-MBP vectors were kind gifts of dr. David S. Waugh (NCI-
Frederick, USA). 
 In the first step the coding sequences of the desired fluorescent proteins were 
amplified by a PCR reaction (100 µl final volume) using 300-300 ng N1 and C primers (5’-
GAGAACCTGTACTTCCAGGGTGGTGCATCTACACGCGGTTTAATTAATCTTCTGCT
AGCATGGTGAGCAAGGGCG-3’) and C primers (5’-
GGGGACACACTTTGTACAAGAAAGCTGGGTTATTACTTGTACAGCTCGTCCAT-3’), 
and 1800 ng mApple-N1 or pPalmitoyl-mTurquoise2 plasmids (Addgene) as templates. 
Reaction mixtures contained Pfu buffer + MgSO4 (10x) (Thermo Fischer Scientific, 
Fermentas), Pfu DNA polymerase (Thermo Fischer Scientific, Fermentas), 10 mM dNTP mix, 
and nuclease-free water (to set final volume to 100 µl). The following PCR protocol was 
used: cycle1 (1x): 5 min at 94°C; cycle2 (30x): 1 min at 94°C, 1 min at 45°C, and 3 min at 
72°C; cycle3 (1x): store at 4°C.  
 The PCR products were separated by gel electrophoresis using 1% agarose gel. The 
linear PCR products (having ~800 base pair lengths) were cut out from the gel and purified by 
Qiagen DNA extraction kit (Qiagen). Twenty-five ng of the purified DNA was used as a 
template in the second PCR reaction (100 µl final volume) containing 300 ng N2 (Thermo 
Fischer Scientific, Invitrogen; 5’-
GGGGACAAGTTTGTACAAAGCAGGCTCGGAGAACCTGTACTTCCAG-3’) and C 
primers, and Pfu buffer + MgSO4 (10x) (Thermo Fischer Scientific, Fermentas), Pfu DNA 
polymerase (Thermo Fischer Scientific, Fermentas), 10 mM dNTP (Biorad) mix, and 
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nuclease-free water (to set final volume to 100 µl). The PCR protocol was the same as in the 
case of the first-step reaction. 
 The PCR products were purified by Qiagen Nucleotide Removal Kit (Qiagen). Three-
hundred ng of the purified linear DNA sequence flanked by attB sites was used in a BP 
reaction (recombination between attB and attP sites) with pDON221 (Thermo Fischer 
Scientific, Invitrogen). Thereafter, LR reaction (for the recombination between attL and attR 
sites) was performed for 4 hours using 300 ng of the purified entry clone and 800 ng pDEST-
His6-MBP destination vector (Addgene). Gateway cloning steps and the following 
transformations were carried out according to the manufacturer’s protocol. 
 
2.2 ‘Cloning cassette’ and the inserted HIV-1 PR cleavage site 
 Circular pDest-His6-MBP-mApple and pDest-His6-MBP-mTurquoise2 expression 
vectors were cleaved by PacI and NheI restriction endonucleases (New England Biolabs). 
Cleavage products were separated by 1% agarose gel electrophoresis, and the linear plasmids 
were cut out from the gel and purified by Qiagen DNA extraction kit (Qiagen). The annealing 
of the complement oligonucleotides coding for the cleavage sites to be inserted, and their 
ligation into the linearized expression plasmids were carried out by the following reactions: 
200-200 ng forward (5’-TAAAGTGAGCCAGAACTATCCGATTGTGCAGG-3’) and 
reverse (5’-CTAGCCTGCACAATCGGATAGTTCTGGCTCACTTTAAT-3’) primers were 
mixed with 150 ng purified linearized expression plasmid. The reaction mixtures were 
incubated at 65°C for 2 minutes and after that at 4°C for 2 minutes. Thereafter, T4 DNA 
Ligase Reaction Buffer (10x) and T4 DNA Ligase (New England Biolabs) were added, and 
the reaction mixture was incubated at 25°C for 1 hour followed by incubation at 16°C 
overnight.  
 Next day 100 µl of Escherichia coli BL21(DE3) competent cells (Thermo Fischer 
Scientific, Invitrogen) were transformed by 15 µl of the ligation reaction mixture by heat 
shock (at 42°C). The transformation reaction was spread on Luria-Bertani (LB) agar plates 
containing 100 µg/ml ampicillin. Grown colonies were cultured at 37°C for overnight in LB 
medium containing 100 µg/ml ampicillin followed by plasmid preparation using Qiaprep Spin 
Mini Prep Kit (Qiagen). DNA sequences of the purified plasmids were verified by capillary 
DNA sequencing using pDest-His6-MBP-FP sequencing forward primer (5'-
GATGAAGCCCTGAAAGACGCGCAG-3'). 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
2.3 Expression of substrates 
 Recombinant substrates were expressed in Escherichia coli BL21(DE3) cells. Cells 
were grown in LB medium containing 100 µg/ml ampicillin at 37°C up to an absorbance of 
0.6-0.8 at 600 nm. Protein expression was induced by the addition of 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) followed by incubation for 3 hours. Cells were harvested by 
centrifugation at 4,000 g for 15 minutes at 4°C (Jouan CR 412). Cell pellets were stored at 
least for 1 hour at -70°C before lysis of the cells, and were let to thaw on ice for 15 minutes. 
Pellets were suspended in 2 ml lysis buffer (50 mM sodium-acetate, 300 mM NaCl, 10 mM 
imidazole, 0.05% Tween 20, pH 8.0) containing phenylmethanesulfonyl-fluoride (PMSF) at a 
final concentration of 25 µg/ml. Lysozyme and DNase enzymes (New England Biolabs) were 
added in 1 mg/ml and 10 U/ml final concentrations, respectively. Cell suspensions were 
vortexed and occasionally mixed during incubation on ice for 10 minutes, then were aliquoted 
into microcentrifuge tubes and sonicated for 3 minutes. Tubes were centrifuged at 10,000 g 
for 20 minutes (Eppendorf 5415D) at room temperature, and the supernatants (cleared 
bacterial lysate containing the desired recombinant fusion substrate) were collected. 
 
2.4 Purification of the substrates 
 Cleared bacterial lysates containing the desired recombinant fusion substrate were 
added to Ni-NTA magnetic agarose beads (Qiagen), the suspensions were incubated at least 
for 20 minutes at room temperature while continuously shaking. Magnetic beads were washed 
three times with 1% Tween 20 (pH 7.0), then washed three times by washing buffer (50 mM 
sodium-acetate, 300 mM NaCl, 5 mM imidazole, 0.05% Tween 20, pH 7.0) and three times 
by cleavage buffer (50 mM sodium-acetate, 300 mM NaCl, 0.05% Tween 20, pH 7.0) using 
DynamagTM-2 magnetic particle concentrator (Thermo Fischer Scientific, Invitrogen). Beads 
were incubated in cleavage buffer for 60 minutes at 37°C while continuously shaking at 600 
rpm and thereafter beads were applied to DynamagTM-2 magnetic particle concentrator 
(Thermo Fischer Scientific, Invitrogen). Supernatants were removed and substrates were 
eluted from the beads using elution buffer (100 mM EDTA, 0.05% Tween 20, pH 8.0). Buffer 
was exchanged to cleavage buffer by using 10K Amicon tubes (Merck-Millipore). Total 
protein concentrations were determined by BCA protein assay (Thermo Fischer Scientific, 
Pierce) and by measuring absorbance at 280 nm by NanoDrop 2000 equipment (Thermo 
Fischer Scientific). Both methods were applied simultaneously to verify the results, but OD 
280 nm values were used for further calculations. 
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2.5 Expression and purification of HIV-1 PR  
 The plasmid coding for the HIV-1 PR was kindly provided by Dr. John M. Louis 
(Laboratory of Chemical Physics, NIDDK, NIH). The HIV-1 PR coding region contained five 
stabilizing mutations (Q7K, L33I, L63I, C67A, and C95A), the construction of the plasmid 
was described previously (Louis et al., 1999; Mahalingam et al., 1999). HIV-1 PR was 
expressed in Escherichia coli BL21(DE3) cells. Cells were grown at 37°C up to an 
absorbance of 0.6–0.8 at 600 nm, in LB medium containing 100 µg/ml ampicillin, and 
induced for expression with 1 mM IPTG for 3 hours. Cells were harvested by centrifugation 
at 6,000 g for 20 min at 4°C. After removal of the supernatant, the cell pellet was treated as 
described previously (Mahalingam et al., 2001). Pellet was suspended in 20 volume of buffer 
A (50 mM Tris, 10 mM EDTA, pH 8.2), and lysed in the presence of 100 µg/ml lysozyme by 
sonication on ice. The lysate was centrifuged at 20,000 g for 20 min at 4°C, suspended in 
buffer B (buffer A containing 2 M guanidine-HCl and 1% Triton X-100) and centrifuged 
again. Pelleted inclusion bodies were suspended in buffer A and centrifuged again. The final 
pellet was dissolved in buffer C (50 mM Tris, 5 mM EDTA, 7.5 M guanidine-HCl, pH 8.0), 
filtered through 0.22 µm pore size filter (Merck-Millipore) and applied to a Superose 12 
10/300 GL column (GE Healthcare) equilibrated in 50 mM Tris, 4 M guanidine-HCl, 5 mM 
EDTA containing buffer (pH 8.0) at a flow rate of 0.5 ml/min at ambient temperature. Peak 
fractions were pooled and subjected to RP-HPLC on a POROS 20 R2 column (Thermo 
Fischer Scientific, Applied Biosystems). Purity of selected fractions was assessed by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) using 16% polyacrylamide 
gels. The protein was folded by dialysis into 0.05 M formic acid at pH 2.8 followed by a 
dialysis using cleavage buffer (50 mM sodium-acetate, 300 mM NaCl, 0.05% Tween 20, pH 
7.0) or 2x cleavage buffer for HPLC assays. 
 
2.6 Gel electrophoresis 
 Purified recombinant protein substrates and cleavage products were analyzed by 
PAGE, using 14% polyacrylamide gel. Two different protocols have been used: i) 6X loading 
buffer (300 mM Tris, 20% glycerol, 0.05% bromophenol blue, pH 6.8) containing no 
reducing agents was added to those samples, which were not heat-treated before the 
electrophoresis (Gross et al., 2000); ii) the samples mixed with 6X loading buffer - 
containing 12% SDS and 100 mM β-mercaptoethanol (β-ME) as reducing agents - were 
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heated at 95°C for 10 minutes. The electrophoresis was followed by washing the gels with 
distilled water for 30 minutes at room temperature. The fluorescent proteins in the unstained 
gels were visualized by using Dark Reader Blue transilluminator and by using UV imaging 
function of an AlphaImager gel documentation system (ProteinSimple). Gels were stained by 
PageBlue Protein Staining Solution (Thermo Fischer Scientific). Densitometry of gels was 
performed by using ImageJ 1.43 software (Schneider et al., 2012) and by GelAnalyzer 2010a 
program (www.gelanalyzer.com). 
 
2.7 Calibration curve of the substrates  
 mTurquoise2 and mApple fluorescent protein-containing substrates were used for 
calibration. The purified substrates were dissolved in elution or cleavage buffer, and the 
solutions containing the substrates in different final concentrations were transferred into black 
half-area plates. Relative fluorescent intensities were measured by Biotek Synergy2 
multimode plate reader using 590/35 nm excitation and 645/40 nm emission filters for 
mApple, while 400/10 nm excitation and 460/40 nm emission filters for mTurquoise2. Blank-
corrected relative fluorescent intensity values (RFU) were plotted against the substrate 
concentration (mM). Linear regression was performed and the parameters of the fitted lines 
were determined by Microsoft Excel 2010 (Microsoft).  
 
2.8 Kinetic and inhibition study using HIV-1 PR  
 Substrates were coated to Ni-NTA magnetic agarose beads as it was described in 2.4 
section. The substrates coated to the beads were suspended in cleavage buffer, and then 
increasing amounts of the homogenous suspensions were measured into 2.0 ml Protein 
Lobind Micro-centrifuge tubes (Eppendorf). The tubes were applied to a DynamagTM-2 
magnetic particle concentrator (Thermo Fischer Scientific, Invitrogen), the supernatant was 
removed and the beads were suspended in equal volume of cleavage buffer. 
 For determining the amount of the substrate attached to magnetic beads, substrate 
control samples were also prepared in the same way as the reaction samples except that the 
suspension was in elution buffer instead of cleavage buffer. 
To determine kinetic time course for the release of proteolytic fragments, cleavage of 
His6-MBP-VSQNY↓PIVQ-mTurquoise2 and His6-MBP-VSQNY↓PIVQ-mApple substrates 
(at 0.0016 mM and 0.0024 mM final concentrations, respectively) by HIV-1 PR (at 36.4 nM 
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final concentration) was followed by measuring fluorescence after 0, 20, 40 and 60 minutes 
incubation. 
 The purified HIV-1 PR was added to each reaction and incubated for 60 minutes at 
37°C while continuously shaking at 600 rpm. Cleavage reactions were performed by using 
36.4 nM HIV-1 PR (final, total enzyme concentration) and substrates containing HIV-1 
matrix and capsid (MA/CA) cleavage site sequence (VSQNY↓PIVQ). Substrate blanks 
(reactions, where cleavage buffer was added instead of the enzyme) at each concentration 
points were also made to detect non-specific substrate dissociations. Reactions were 
terminated by separating the magnetic beads on DynamagTM-2 magnetic particle concentrator 
(Thermo Fischer Scientific, Invitrogen) and supernatants were measured as described in 2.7 
section. 
 Initial velocity values (nMs-1) were calculated from the blank-corrected RFUs using 
the slope of the substrate calibration curves in cleavage buffer and were plotted against the 
coated substrate concentration (mM) assessed from substrate control sample using the slope 
of the substrate calibration curve in elution buffer. Kinetic parameters were determined at less 
than 20% substrate turnover by Michaelis-Menten non-linear regression analysis using 
GraphPad Prism version 5.00 for Windows (GraphPad Software, La Jolla, California USA, 
www.graphpad.com).  
 His6-MBP-VSQNY↓PIVQ-mTurquoise2 recombinant substrate (0.028 mM final 
concentration) was used to study inhibitory effect of amprenavir (ranging from 1nM to 1µM 
final total concentrations) on HIV-1 PR (at 36.4 nM final concentration). After the 
termination of the reactions the fluorescence of supernatants was measured. Initial velocity 
values (nMs-1) were plotted against the logarithms of amprenavir concentrations (nM). 
Inhibitory effect at 50% initial velocity value (IC50) was determined by fitting five parameter 
logistic curve on the data using GraphPad Prism version 5.00. Data of the present inhibitory 
measurement was applied for the determination of active enzyme concentration used for 
assessing kinetic parameters and inhibitory constant. The inhibitory constant (Ki) value was 
calculated from the IC50 value using the following equation: Ki = (IC50-[E]/2)/(1+[S]/Km), 
where [E] and [S] are the concentrations of active enzyme (6.05 nM) and substrate, 
respectively, while Km is the Michaelis constant.  
  
2.9 Kinetic and pH dependence study of TEV PR 
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TEV PR stock solution, purified by the method of Kapust and its co-workers (Kapust 
et al., 2001), was a kind gift of dr. David S. Waugh (NCI-Frederick, USA). 
His6-MBP-VSQNY↓PIVQ-mTurquoise2 and His6-MBP-VSQNY↓PIVQ-mApple 
recombinant substrates were used to study the cleavage kinetics of TEV PR (the final 
concentration of the enzyme in the kinetic assays was 45.71 nM). Kinetic reactions were 
performed as described in 2.8 section, but incubation temperature was set to 30°C.  
His6-MBP-VSQNY↓PIVQ-mTurquoise2 recombinant substrate (at 0.03 mM final 
concentration) was used to study pH dependence of TEV PR. Substrates coated to Ni-NTA 
magnetic beads were purified as it was described in 2.4 section, but the pH of cleavage buffer 
was different (pH was set to 6.0, 6.5, 7.0, 7.5, 8.0, and 8.5). The final concentration of TEV 
PR was 91.42 nM in the reaction mixtures. Substrate blank samples (where enzyme buffer 
was added instead of the enzyme) were also prepared for each reaction to detect the 
dissociation of substrates from the beads at different pH values (the composition of the 
enzyme buffer was described previously in Kapust et al., 2001). After the termination of 
reactions the fluorescence of supernatants was measured as it was described in 2.8 section. 
Initial velocity values (nM-1s-1) were plotted against pH.  
 
2.10 Recycling of the magnetic beads 
 Ni-NTA magnetic beads (Qiagen) were used repeatedly during the experiments; the 
beads were regenerated before each use. Different buffers were used for all six washing steps 
of regeneration: (i) 0.5 M sodium-hydroxide and 0.05% Tween 20; (ii) 0.05% Tween 20; (iii) 
elution buffer; (iv) 0.05% Tween 20; (v) 100 mM NiSO4 and 0.05% Tween 20; (vi) and 
0.05% Tween 20. Each washing step was repeated five times. For long-term storage the beads 
were suspended into 30% ethanol containing 0.5% Tween 20 (pH 7.0). 
 
2.11 HPLC-based protease assay 
 The protease assays were initiated by the mixing of 5 µl purified HIV-1 PR (dialyzed 
against 2X cleavage puffer, 430 nM final concentration), 10 µl 2X cleavage buffer, and 5 µl 
synthetic oligopeptide substrate (in 0.47-2.35 mM final concentrations) representing the 
naturally occurring MA/CA cleavage site of HIV1 PR (VSQNY↓PIVQ).  
 The reaction mixtures were incubated at 37°C for 10 minutes and stopped by the 
addition of 9 volumes of 1% trifluoroacetic acid (TFA). The samples were injected onto 
Nova-Pak C18 reversed-phase chromatography column (Waters Associates, Inc.) using an 
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automatic injector. Separation of substrates and cleavage products was performed by using 
acetonitrile gradient (0 to 100%) in water, in the presence of 0.05% TFA. We monitored the 
cleavage of peptides at 206 nm, followed by integration of the peak areas. Reactions were 
monitored at < 20% substrate hydrolysis. 
Active enzyme concentration (22.05 nM) was determined the same way as kinetic 
measurements except that 2X cleavage buffer contained amprenavir as a potent inhibitor 
(final concentration ranging from 1 nM to 80 nM in reaction mixtures) at 0.47 mM final 
oligopeptide substrate concentration. 
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3. Results and discussion 
 
3.1 Structure of the expression vectors  
 pDest-His6-MBP-mApple and pDest-His6-MBP-mTurquoise2 plasmids were prepared 
by using Gateway cloning technology based on the description of Tropea et al. (2007). We 
have designed N1 primer of the first PCR reaction in a way that besides amplifying the 
desired FP, it also codes for a so called ‘cloning cassette’, which is located between the TEV 
PR cleavage site and the FP. The schematic structure of a pDest-His6-MBP-FP plasmid is 
illustrated in Figure 1. 
 Both pDest-His6-MBP-mApple and pDest-His6-MBP-mTurquoise2 plasmids carry the 
coding sequence of a His6 affinity tag and a MBP fusion protein, followed by a TEV PR 
cleavage site (ENLYFQ↓G), the ‘cloning cassette’, and a C-terminal fluorescent protein (FP). 
 The nucleotide sequence coding for the desired proteolytic cleavage site can be 
inserted into the ‘cloning cassette’, which contains cleavage sites of PacI and NheI restriction 
endonucleases next to each other (see Figure 1). The plasmids linearized by PacI and NheI 
restriction enzymes have sticky ends and can be re-circularized after the addition of a linear 
dsDNA sequence flanked by PacI and NheI sticky ends. In our case, short and linear dsDNA 
sequences to be inserted were created by the attachment of complementary, E. coli-optimized 
(forward and reverse) oligonucleotide primers, which code for a cleavage site sequence of 
HIV-1 PR. The coding sequence of the HIV-1 PR cleavage site was inserted into pDest-His6-
MBP-mApple and pDest-His6-MBP-mTurquoise2 plasmids by ligation.  
 It is important to note that the coding sequences of the fluorescent proteins are not in 
the open reading frame without the insertion of the properly designed linear dsDNA-s into the 
plasmids, therefore, the fluorescent proteins are translated only after a successful ligation.  
 
3.2 The fluorescently labeled recombinant fusion protein substrates 
 Recombinant fusion proteins were expressed to contain an N-terminal hexahistidine 
affinity tag (His6) and a maltose binding protein (MBP), followed by cleavage sites of TEV 
and HIV-1 proteases, respectively, while on the C-terminal end a fluorescent protein variant is 
fused to the cleavage site to be processed. The role of the His6 affinity tag is to enable the 
recombinant proteins to be immobilized on metal-chelate surfaces, and also to make the 
purification of the proteins by immobilized metal affinity chromatography (IMAC) possible. 
The N-terminal MBP fusion protein enhances the water-solubility of the recombinant protein 
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substrate and improves its folding (Kapust et al., 1999; Fox et al., 2003; Fox and Waugh, 
2003), while TEV protease cleavage site serves as an internal control cleavage site. Here we 
applied plasmids coding for C-terminal mApple or mTurquoise2 fluorescent proteins (Shaner 
et al., 2008; Goedhart et al., 2012). Compared to other similar protease assays (Patel et al., 
2001; Chaparro-Riggers et al., 2005), our recombinant substrates contain an MBP fusion 
tag, as well, to provide a spacer preventing the possible influence of substrate immobilization 
on the enzyme kinetic parameters. Therefore, the cleavage sites of TEV and HIV-1 proteases 
are not located in the close proximity of the affinity tag responsible for the binding to the 
magnetic beads, and the flexibility of this MBP-FP interdomain linker provides sufficient 
accessibility of the cleavage sites in the immobilized substrates. 
 In our experiments, the recombinant protein substrates contained a cleavage site 
sequence in order to carry out activity measurements of HIV-1 PR. The inserted (9 residue- 
long) sequence represented the P5-P4’ amino acid residues of the naturally occurring cleavage 
site between the matrix and capsid (MA/CA) of HIV-1 polyprotein (Tözser et al., 1991).  
 The recombinant substrates were successfully expressed in E.coli BL21(DE3) strain 
and the desired proteins were recovered from the cell lysate under native conditions for the 
purification and for the protease assay using Ni-NTA coated agarose beads. 
The expressed fusion protein substrates in the cleared bacterial lysates were attached 
to Ni-NTA coated magnetic agarose beads. After the cleavage by HIV-1 PR or by TEV PR, 
the N-terminal part of the processed substrates remained attached to the magnetic beads and 
could be separated by a magnetic particle concentrator, while the fluorescent C-terminal part 
could be well-detected in the supernatant, based on which kinetic parameters can be 
calculated. The process of the assay is illustrated in Figure 2. 
Ni-NTA beads were utilized not only for assay purposes, but also for purifying the 
substrates from the cleared bacterial lysates. Gel electrophoresis analysis of the purified 
substrates demonstrated that the fusion proteins had the expected molecular weight (~72 
kDa) and purity for the assay. We have also verified that both TEV PR (data not shown) and 
HIV-1 PR cleaved the recombinant substrates efficiently, the cleavage products can be well-
differentiated and visibly detected on the gel (Figure 3). 
Effect of temperature on the stability of fusion protein substrates was also studied. We 
examined the effect of storage at 4°C and incubation at 37°C on substrate degradation. 
Stability assays were assessed by densitometric analyses of gels from repeated denaturing 
SDS-PAGE analyses (data not shown). We observed no significant substrate degradation 
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neither for storage at 4°C for at least two weeks nor for incubation at 37°C for 24 hours. 
Conformational stability of the His6-MBP-VSQNY↓PIVQ-mApple recombinant substrate 
was assessed by tryptic digestion, as well (see methods and results in Mótyán et al., 
submitted). Results of this enzymatic analysis indicated proper folding of the substrate. We 
observed no decrease in band intensities for the Coomassie-stained protein products (data not 
shown) and for the UV image of mApple after in-gel renaturation (see section 3.3), which 
implied no degradation of the fusion partners while the accessible interdomain linker was 
cleaved by trypsin. 
 
3.3 In-gel renaturation of fluorescent proteins 
 The purified recombinant protein substrates and cleavage products were analyzed by 
PAGE, using denaturing or non-denaturing conditions during the sample preparation, while 
polyacrylamide gels contained SDS in both cases. The samples, which were not denatured 
were treated with loading buffer containing no reducing agents and were not heat-treated 
before the electrophoresis. Loading buffer containing SDS and β-ME was added to the 
samples to be heat-treated for the denaturation of proteins.  
 The fluorescence of the bands in the case of non-denatured samples was readily 
detected by blue light transilluminator (Figure 3A) and by UV imaging (Figure 3B) using a 
gel documentation system after the electrophoresis. The presence of SDS in the gels makes 
the detection of the fluorescence of denatured fluorescent proteins impossible, furthermore, it 
interferes with Coomassie staining. Therefore, the electrophoresis was followed by washing 
the gels with distilled water to remove SDS and renature the proteins. We found that removal 
of the SDS from the gels made the detection of fluorescence possible by using blue light 
transilluminator and UV imaging (Figure 3A and 3B).  
 To our knowledge, protocol for the detection of fluorescent proteins after a denaturing 
SDS-PAGE analysis (including heat-treatment) by washing out the SDS from the gel has not 
been published till now.  
 The fluorescence of denatured recombinant protein substrates and products were 
successfully detected in the gel by UV imaging after the removal of SDS, because the 
washing step was found sufficient for at least partial renaturation of the proteins. The 
advantage of the application of protein denaturation/renaturation in this protease assay is that 
the cleavage products can be separated from each other based on their molecular weight, and 
their native charge or shape does not affect their migration during electrophoresis. Besides the 
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differentiation based on protein size, the appropriate bands can be identified based on their 
fluorescence, as well. The protein size-based identification could be relevant if the molecular 
weights of other cleavage products (or contaminants) having no fluorescence closely resemble 
to those of the fluorescent products. This is represented in Figure 3C, where the cleavage 
products are not separated fully from each other in the case of non-denaturing electrophoresis, 
while can be differentiated in renatured samples after Coomassie staining of the gel (Figure 
3C). In the case of multiple cleavages within the inserted target sequence, the cleavage 
products having different molecular weights may be also identified by denaturing gel 
electrophoresis, while cannot be differentiated purely based on measuring the fluorescence of 
the supernatant.  
 We have investigated the resolution ability of the polyacrylamide gel electrophoresis 
to separate cleavage products having similar molecular weights. His6-MBP-VSQNY↓PIVQ-
mApple recombinant protein substrate was digested by HIV-1 and TEV proteases, and the 
proteolytic fragments were separated by SDS-PAGE using a 14% polyacrylamide gel. The 
~1.5 kDa differences between the cleavage products, which showed only 15 amino acid 
residue difference in their lengths, were clearly visible in the Coomassie-stained gel (Figure 
3D). This implies that SDS-PAGE may be indicative of alternative cleavages within the 
substrates, and the proteolytic fragments showing only slight differences in their molecular 
weights can be differentiated. As the resolution is strongly dependent on the type of the 
applied gel, theoretically it can be further improved by increasing the gel concentration or by 
applying tricine-SDS-PAGE. 
 It is important to note that differences were observed in the renaturation of mApple 
and mTurquoise2 fluorescent proteins. mTurquoise2 showed substantially better renaturation 
ability compared to mApple, when detected by blue light transilluminator and UV imaging 
(Figure 3A). While band intensity of renatured mTurquoise2 compared to the non-denatured 
was at least 50% based on densitometry, mApple showed only ~10% fluorescence intensity 
but was detectable in the gel under UV light (Figure 3B). It has already been reported by 
Gross et al. (2000) that the acylimine bond of the dsRed chromophore is irreversibly degraded 
upon denaturation. The acylimine bond, being responsible in part for the red shift of mApple 
(Shu et al., 2006) may be also disrupted upon denaturation and this change can be possibly 
responsible for the lower renaturation ability of mApple. While detailed analysis of the 
changes induced by denaturation may help understanding the differences between the 
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sensitivity of the fluorescent proteins, the investigation of renaturation abilities was out of the 
scope and extent of this study. 
 
3.4 Substrate calibration curves 
 We have tested whether the fluorescence intensity of the purified substrates is 
proportional to their concentration. Relative fluorescence intensities of substrates in either 
elution or cleavage buffers were measured to prepare the calibration curves. Based on the 
calibration we found that the relative fluorescence intensities are directly proportional to the 
substrate concentration in the range applied in our experiments (Figure 4). 
 
3.5 Kinetic and inhibition study of HIV-1 PR 
 Although published in vitro protease assay systems (Chaparro-Riggers et al., 2005; 
Patel et al., 2001; Askin et al., 2011; Zhou et al., 2014) may be adapted to several proteases, 
to our knowledge, the applications of fluorescent protein-based assays for the measurement of 
HIV-1 PR activity have not been published so far. 
 In order to demonstrate the suitability of the described protease assay system, we 
performed enzyme kinetic measurements by using substrates, which contain the HIV-1 
MA/CA cleavage site sequence. Kinetic parameters summarized in Table 1A show that 
kcat/Km values for HIV-1 PR measured on mApple and mTurquoise2 substrates are practically 
identical, while the individual kcat and Km values differed substantially. Representative graphs 
for non-linear regression analyses of measured data are shown in Figure 5A and B, and 
Figure 5C and D graphs show that kinetic time courses are linear for the fluorescent cleavage 
products. For comparative purposes we have also determined the kinetic parameters for HIV-
1 PR using an oligopeptide substrate (Table 1B), where folding efficiency of HIV-1 PR was 
calculated to be 5.13 %. The kcat/Km values determined for HIV-1 PR by oligopeptide 
substrate closely resemble that of measured by the recombinant protein substrates, while the 
individual kinetic parameters were substantially higher in the peptide assay. These differences 
might be accounted for the effect of different substrate types, like extended binding site and 
effect of neighbouring protein domains on the cleavage site flexibility. Our previously 
published much higher specificity constant (45.3 mM−1 s−1) for the oligopeptide substrate 
representing the same cleavage site was determined under very different assay conditions, 
including the different buffer systems, which have different pH (pH 5.6) and ionic strength (2 
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M) (Tözsér et al., 1991) compared to the recombinant protein substrate-based assay (pH 7.0 
and 300 mM NaCl concentration). 
 It is important to note, that the recombinant fusion protein-based assays were 
performed at pH 7.0, because substrates attachment to the bead-surface is pH dependent and 
most effective over pH 6.0. However, the applied pH is higher than in the case of synthetic 
oligopeptide substrate-based HPLC assays (pH 5.6) (e.g. Fehér et al., 2006; Eizert et al., 
2008), the HIV-1 PR activity was successfully measured at neutral pH on the recombinant 
fusion protein substrates. It should be noted that in our assay relatively low salt concentration 
(300 mM NaCl) was applied compared to the high salt concentration (2 M or more), which 
was previously found to be optimal for retroviral proteases and was used in common HPLC-
based assays (e.g. Bagossi et al., 2004; Fehér et al., 2006).  
 The HIV-1 protease inhibitor amprenavir was used at increasing concentrations to test 
its inhibitory effect on the cleavage of His6-MBP-VSQNY↓PIVQ-mTurquoise2 fusion protein 
substrate by HIV-1 PR. The sigmoid dose-response curve (represented in Figure 6) was used 
to determine IC50 (21.43 nM) and Ki values (6.75 nM).  
 Our results demonstrate that this substrate system is suitable to study the inhibitory 
potential of protease inhibitors on the enzyme activity. 
 
3.6 Kinetic and pH dependence study of TEV PR 
In order to examine the internal control TEV PR cleavage site of the fusion protein 
substrates, kinetic measurements by TEV PR were also performed on His6-MBP-
VSQNY↓PIVQ-mTurquoise2 and His6-MBP-VSQNY↓PIVQ-mApple substrates. 
Values summarized in Table 1A show that kinetic parameters determined on mApple 
and mTurquoise2 substrates are very similar, and the kcat/Km value is also similar to what was 
determined for TEV PR using an oligopeptide substrate TENLYFQ↓GGTRR (3.08 ± 0.67 
mM−1 s−1; Kapust et al., 2002), while both the Km and kcat values are substantially lower than 
those found in the peptide-based assay (Km = 0.087 ± 0.017 mM; kcat = 0.27 ± 0.03 s-1; 
Kapust et al., 2002). Differences may be attributed to the different substrate types as detailed 
for HIV PR cleavage, furthermore, the buffer systems and ionic strengths were also different 
in the oligopeptide- and the recombinant protein-based protease assays (400 mM and 300 mM 
NaCl, respectively), furthermore, no reducing agents were added to the buffer in the herein 
described protease assay, while activity measurements of TEV PR have been performed in the 
presence of DTT (Kapust et al., 2002). 
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TEV PR was found previously to have no activity at or below pH 5.0 but is active 
over a pH range between 6.0 and 9.0 (Parks et al., 1995), therefore, this enzyme was chosen 
to demonstrate that the method is suitable for the determination of the pH dependence of 
enzymes that prefer alkaline reaction conditions (Figure 7). TEV PR activity was measured in 
the 6.0-8.5 pH range, and we found no statistically significant differences between the 
activities measured at pH 6.5, 7.5, 8.0, and 8.5 compared to the highest activity observed at 
pH 7.0. These results are in agreement with the literature data (Parks et al., 1995) and imply 
an optimal pH range for TEV PR.  
Standard deviation (SD) at pH 6.0 was found to be relatively high compared to SDs 
of the results at other pHs (data not shown). This phenomenon may be caused by the nature of 
the interaction between the Ni-NTA agarose bead and the His6 fusion tag of a protein 
substrate, which significantly weakens at or under pH 6.0 (in agreement with the manu-
facturer’s specifications). Our results also showed substantial substrate dissociation at pH 6.0, 
while only weak dissociation was observed at higher pH (Figure 8). Spontaneous substrate 
dissociation was considered during the evaluation of kinetic measurements and values 
measured for the enzyme reactions have been corrected by the fluorescence of substrate blank 
samples. 
 
3.7 Advantages and limitations of the assay system 
 Due to the flexibility of the ‘cloning cassette’, the expression system allows easy 
generation of a substrate library, the desired oligonucleotide sequences can be inserted into 
the ‘cloning cassette’ simply by a one-step PCR reaction. The expression construct was 
designed to make the ligation efficiency easy-to-follow by a simple transilluminator, because 
the FP is only translated if the insertion of the cleavage site is successful. 
 Besides the mApple and mTurquoise2, other fluorescent proteins (e.g. mCherry, green 
fluorescent protein, etc.) can be also attached to the fusion protein by the modification of the 
expression construct. Since 3’ and 5’ ends of the DNA sequences of the most commonly used 
fluorescent proteins are highly similar, numerous plasmid variants can be created by using 
only one pair of N1 and C oligonucleotide primer. Fluorescent proteins ensure highly 
sensitive fluorescent detection in the designed assay and - as an extra advantage - it makes the 
recombinant fusion substrate easy-to-follow during expression, purification and working 
procedures. Fluorescent proteins that most suit the experimental purposes and the given 
instrumentation can be chosen (Davidson et al., 2009).  
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 Although protease assay systems based on the use of recombinant protein-based 
substrates (consisting of an affinity tag, a proteolytic cleavage site of interest, and a 
fluorescent protein) have already been developed (Patel et al., 2001; Chaparro-Riggers et 
al., 2005; Askin et al., 2011), our system may provide a novel tool for protease research by 
combining and also improving the advantages of the already developed methods by offering a 
true separation-based assay that enables the determination of protease kinetic parameters (kcat, 
Km) supported by a detailed substrate quantification procedure (linearity of the fluorescence 
versus substrate concentration is examined in a wide concentration range, also considering the 
difference in the relative fluorescence in elution and cleavage buffer) in a low volume, HTS-
compatible format, utilizing a fusion protein substrates equipped with MBP to enhance 
protein solubility, built-in TEV PR cleavage site to serve as a control cleavage site, and with 
monomeric FPs to avoid substrate aggregation. Moreover, for a simple and fast demonstration 
of cleavage of the desired substrate with a specific enzyme, the fluorescent substrates and the 
generated products can be visualized by gel electrophoresis (Figure 3). Our observations were 
in agreement with the previous observations of Saeed and its co-workers, who found that the 
fluorescent proteins exposed to denaturants show differences in their stability despite the 
close relationships (Saeed et al., 2009). Therefore, abilities of proteins for renaturation need 
to be considered in the experimental design, fluorescent proteins with higher stability need to 
be chosen or in-gel renaturation needs to be further optimized to make the detection of less-
stable proteins sensitive enough.  
 The herein described recombinant fusion protein substrate-based protease assay has 
the advantage that it can be effortlessly adapted to HTS environment (Inglese et al., 2007) 
due to the followings: (i) the reaction can be well performed using small volume of reagents 
(in our case total reaction volume was under 70 µl); (ii) no built-in factors of the system limit 
the lengths of the assay procedures, it depends only on the incubation time; (iii) the assay 
procedure itself consists only of 6-7 short steps that are fully automation compatible; (iv) no 
special instrumentation is needed, which makes the assay especially cost-efficient. 
 Due to the nature of the fluorescence read out, the assay is highly sensitive, and 
despite of the fact that it is an endpoint method, the system also offers good relative 
estimation of the catalytic efficiency. Other attractive feature of the assay is that simple and 
safe operation is ensured during the whole process.  
 Since both the substrates and the products have similar fluorescence due to the 
presence of the fluorescent protein tag, they cannot be differentiated in solution by 
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fluorimetric measurements, therefore, in our assay system the substrates are attached to 
magnetic beads to make the separation of the cleavage fragments (present in the supernatant) 
from the uncleaved proteins possible, likewise in the case of other similar assays (Patel et al., 
2001; Chaparro-Riggers et al., 2005). On the other hand it is also possible to study 
proteolytic cleavage of the previously purified recombinant substrates by in-solution 
digestion, and in this case uncleaved substrates and the cleavage fragments can be 
differentiated by electrophoretic separation and molecular weight-based identification. 
 We have also tested the feasibility of the solution phase-extraction method for the 
removal of the substrates and processed N-terminal fragments from the reaction mixtures. 
Purified His6-MBP-VSQNY↓PIVQ-mApple substrate was incubated with the Ni-NTA coated 
magnetic beads, and the dependence of substrate binding on bead concentration and 
incubation time was studied (see methods and results in Mótyán et al., submitted). It was 
found that the substrates are able to be withdrawn from the solution by the addition of Ni-
NTA magnetic beads, and increasing bead concentration or incubation time also resulted in 
elevated attachment of the substrates to the beads. This implies that the magnetic beads may 
be useful for the removal of uncleaved substrates from the reaction mixtures in the case of an 
in-solution digestion assay, however, the optimization of the binding conditions (bead 
concentration and incubation time) is necessary. Avoiding the use of long incubation time is 
advisable, and high bead concentrations could possibly make handling the mixtures difficult 
especially in a low volume format. It is also important to note that in order to set an in-
solution protease assay, beyond the optimization of substrate removal, a proper method that 
do not interfere with the magnetic beads and with the fluorescence of the recombinant 
proteins, is also needed to be optimized to stop the cleavage reaction.  
 Two methods widely applied for stopping enzymatic reactions have been tested by 
examining the bead-binding and fluorescence properties of His6-MBP-VSQNY↓PIVQ-
mApple substrate after trichloroacetic acid (TCA)- and heat-treatments (see methods and 
results in Mótyán et al., submitted). As it was expected, TCA-treatment (using TCA in 5% 
final concentration) abolished fluorescent property of the substrate and prevented effective 
binding of the substrate to the magnetic beads. Interestingly, heat-treatment (incubation at 
95°C for 10 minutes) has not caused the total loss of fluorescent property of the substrate, 
approximately 50% decrease in the signal intensity was observed, and similarly to TCA-
treatment, it also substantially inhibited bead attachment. The above mentioned methods were 
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not found to be useful for stopping the reaction due to their adverse effects on the 
fluorescence properties of the substrates. 
 Some more features that can make the system more attractive is that based on our 
observations one calibration curve suits for a set of substrates (data not shown), the 
measurements are characterized by low level of impurities and due to the strong nature of 
His6-tag and Ni-NTA interactions the background of the measurement due to non-specific 
substrate leakage is especially low. 
 However, just like any other analytical and screening methods this protease assay 
system also has some of its limitations. For example, the reaction and buffer conditions must 
be adjusted to the optimal conditions of Ni-NTA magnetic beads, and the effective attachment 
of the substrates to the bead-surface is pH dependent. According to the manufacturer’s 
handbook, monomer proteins start to be released from the bead surface at pH 5.9, whereas 
multimers are released at pH 4.5. Although the presented assay works reliably over pH 6.0, in 
some cases lower pHs may also be applied, however, the rate of spontaneous substrate 
dissociation at each reaction must be followed by appropriate control reactions and must be 
considered at the evaluation of the results. We also observed increased spontaneous 
dissociation of substrates at pH 6.0, while increasing the pH led to weaker dissociation 
(Figure 8). 
 In our experiments purified enzymes were applied in cleavage reactions, but in some 
cases the use of unpurified protease solutions may also be desired. Working with crude cell 
lysates needs to be carefully optimized, the nature of the protease of interest and the sample 
origin (e.g. bacterial, eukaryotic) is also required to be considered. To avoid unwanted 
cleavages by other proteases which may cause distortion of the results, the application of 
protease inhibitor cocktails may also be necessary. An in silico prediction (performed by the 
PeptideCutter module of ExPASy, accessible at http://web.expasy.org/peptide_cutter) showed 
the presence of possible cleavage sites for several proteases within the recombinant protein 
substrate sequences. This implies that addition of a crude cell lysate to the purified 
recombinant substrate may cause cleavages at multiple sites. However, it is important to note 
that we have tested the susceptibility of a recombinant substrate towards digestion by trypsin, 
and our results showed proper folding of the expressed substrates, thus no degradation of the 
fusion partners was observed. This implies that the MBP and fluorescent proteins may be not 
cleaved efficiently by endogenous proteases, but the interdomain linkers are accessible and 
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can be sensitive towards proteolysis by endogenous proteases. In the case of total cell lysate 
samples the in-gel detection may be problematic in Coomassie-stained gels because the bands 
of substrate and cleavage products are buried with the endogenous protein bands, but 
according to our denaturing SDS-PAGE analyses the fluorescent proteins can be properly 
detected in gels by UV imaging (data not shown). While the recombinant substrates may be 
useful only for the detection of protease activities of unpurified proteases, a great 
disadvantage of this application is that it is not useful for determination of enzyme kinetic 
parameters. 
 Our studies showed stability of the recombinant substrates, which implies that longer 
incubation times may be also used in the designed protease assay system due to the stability 
of the recombinant substrates at 37°C for at least 24 hours. Conformational stability of the 
substrates was proved by tryptic digestion, proper folding of the recombinant protein 
prevented fragmentation the fusion partners. 
 Future users may also need to pay special attention to the type of the applied 
fluorescent protein tags in the reaction, since fluorescent proteins have the tendency to 
produce dimers and some of them may be unstable, therefore, monomer and stable variants 
are preferred (Shaner et al., 2005; Shaner, 2014). 
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4. Conclusions 
 
 Here we describe the development and application of a recombinant fusion protein 
substrate-based protease assay. 
 Plasmids coding for the backbone of the recombinant, fluorescent protein-coding 
substrates were created using Gateway cloning technology. Each expression construct 
comprises the coding sequences of a His6 and an MBP N-terminal fusion tag, a TEV PR 
processing site, a ‘cloning cassette’, and a C-terminal fluorescent protein. Linear DNA 
sequences coding for the cleavage sequences to be examined can be inserted into the designed 
‘cloning cassettes’ of the plasmids by ligation. The whole fusion protein substrates can be 
expressed in E. coli BL21(DE3) cells and purified by Ni-NTA-coated magnetic agarose 
beads. The bead-attached recombinant protein substrates containing the sequences to be 
cleaved are processed by the protease of interest. The reaction can be terminated by the 
removal of the N-terminal products by using a magnetic particle separator, and based on the 
detected fluorescence of the released C-terminal fluorescent products the kinetic parameters 
can be determined. Ni-NTA coated magnetic agarose beads facilitate the easy purification of 
the intact protein substrates for other analytical purposes, e.g.: substrate calibration, protein 
content determination or PAGE. Due to the fluorescent properties of the protein substrates the 
whole working procedure is especially easy to follow visually. 
 The protease assay was successfully applied for the activity measurements of a HIV-1 
PR and TEV PR. The assay system was found to be useful to determine enzyme kinetic 
parameters, to determine the inhibitory potential of amprenavir on HIV-1 PR, and the pH 
dependence of TEV PR, as well. 
Our protease assay system shares some similarities with previously developed 
methods (Patel et al., 2001; Chaparro-Riggers et al., 2005; Askin et al., 2011), that are also 
based on the use of recombinant protein substrates containing an affinity tag (for substrate 
immobilization) and a fluorescent fusion tag (for detection) besides the proteolytic cleavage 
sites. The bead-attached substrates and the protease cleavage-released products can be 
quantified by fluorimetric measurements. However, these recombinant protein substrate-based 
assays are theoretically suitable for kinetic measurements, only one of these assays 
(Chaparro-Riggers et al., 2005) have been used for the determination of kinetic parameters 
for the studied enzyme. Similarly to the substrate designed by Patel et al. (2001), our 
substrates also contain a control cleavage site for TEV protease. 
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Our assay format integrates most of the advantages of previously mentioned fusion 
protein-based platforms, furthermore, important assay elements of these methods are applied 
in an improved format. Furthermore, despite the above mentioned similarities, our assay was 
designed to contain improvements compared to the previously described systems. An 
advantage of our system is the possibility for the determination of the kinetic parameters 
supported by a detailed substrate quantification procedure (linearity of the fluorescence versus 
substrate concentration is examined in a wide concentration range, also considering the 
difference in the relative fluorescence in elution and cleavage buffer), which helps the 
generation of more reliable results. Moreover, a completion of the recombinant substrates has 
been also performed by the insertion of an MBP fusion protein prior to the protease cleavage 
sites to improve the folding efficiency and solubility of the substrates, further expanding the 
potential use of our assay system. Introduction of MBP was expected to minimize possible 
effects of immobilization on substrate cleavage due to the increased distance between the 
cleavage sites and the affinity tag. However, adverse effects of immobilization (due to the 
proximity of the cleavage site sequences to the affinity tags) have not been described for the 
similar assays (Patel et al., 2001; Chaparro-Riggers et al., 2005). Another advantage of this 
system is the lowered volume format (final volume of reaction mixtures is ≤70 µl), which 
altogether with a simplified assay procedure makes the assay compatible with HTS systems. 
By the application of the recently engineered monomeric mApple and mTurquoise2 
fluorescent proteins the potential aggregation of substrates can be minimized. 
 While most HIV protease assays are based on the use of oligopeptide substrates, for 
studying the external binding sites of the HIV-1 PR and other retroviral or retroviral-like 
proteases elongated substrates are necessary. The application of the recombinant fusion 
protein substrates provide good alternative for the synthetic oligopeptide substrates. One of 
the main advantages of the developed protease assay is that both the full-length substrates and 
the cleavage products can be readily detected visually or by blue transilluminator or UV 
imaging system after PAGE analysis. We found that the in-gel UV detection of the 
recombinant protein substrates and cleavage products containing a fluorescent protein tag is 
also possible after the in-gel renaturation of the proteins after a denaturing SDS-PAGE 
(including heat-treatment of the samples). Stability of the substrates provides their storage at 
4°C and makes the application of longer incubation times at 37°C possible.  
 Due to the flexibility of the assay system, wide variety of the sequences can be easily 
ligated into the ‘cloning cassettes’ of the expression plasmids. The cost-efficient and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
27 
 
expeditious generation of the fluorescent fusion substrates harbouring the cleavage site of 
interest, makes the system especially attractive for the generation of substrate libraries, by 
which the method can be a good alternative tool of protease specificity measurements (e.g. 
similar to ones described by Eizert et al. 2008), mutagenesis studies, or due to the HTS-
compatible format of the entire assay procedure (from bacterial cell disruption to the 
determination of the kinetic parameters), it could be also effectively utilized for industrial 
protease inhibitor screening and/or antiviral drug development. Moreover, in principle, by 
mixing substrates bearing different C-terminal fluorescent tags, the assay may be suitable for 
the examination of competitive proteolysis of a protease of interest on different cleavage sites, 
in one reaction. Further investigation and optimization of the assay for this future application 
is also in the scope of our laboratory. 
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Figure legends 
 
 
Figure 1. Schematic representation of the pDest-His6-MBP-FP expression vector coding 
the recombinant fusion protein substrates. Nucleotide sequence of the ‘cloning cassette’ is 
also indicated, recognition sequences of PacI and NheI endonucleases are underlined, while 
restriction endonuclease cleavage sites are indicated by asterisks. His6: hexahistidine tag; 
MBP: maltose binding protein; TEV: tobacco etch virus; FP: fluorescent protein. Arrow 
shows cleavage position in TEV protease cleavage site (ENLYFQ↓G). 
 
Figure 2. Principle of the fluorescent protease assay. The cleavage of the recombinant 
substrate by HIV-1 PR is illustrated on the example of His6-MBP-VSQNY↓PIVQ-
mTurquoise2 substrate. C-terminal part of the substrate (containing the fluorescent tag) is 
released by the proteolysis into the supernatant and can be detected by fluorimetry. 
 
Figure 3. In-gel renaturation of recombinant fluorescent protein substrate and cleavage 
products. Purified His6-MBP-VSQNY↓PIVQ-FP proteins were used as substrates for 
cleavage by HIV-1 PR. Both non-denatured and denatured/renatured samples were analyzed 
by SDS-PAGE. Sample denaturation was performed by heat-treatment of the samples at 95°C 
in the presence of SDS and β-ME. A) The unstained gels were illuminated by blue light 
transilluminator before (left panel) and after (right panel) washing the gel, as well. 
Fluorescent bands of the molecular weight standard are also indicated. B) Bands of the 
recombinant substrates are also shown and represent more efficient renaturation of 
mTurquoise2 fluorescent protein compared to mApple, as it was visualized under UV light 
after washing the SDS out from the gel. C) In the case of denaturation, the two cleavage 
products of His6-MBP-VSQNY↓PIVQ-mTurquoise2 substrate were separated from each 
other based on their molecular weight, and can be differentiated in the Coomassie-stained gel, 
while less prominent separation was observed for the non-denatured sample. D) His6-MBP-
VSQNY↓PIVQ-mApple substrate was cleaved by HIV-1 or TEV proteases and the cleavage 
fragments were separated on 14% polyacrylamide gel after denaturing the samples, the gel 
was stained by Coomassie dye. The proteolytic cleavage sites are underlined within the 
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sequences of MBP-mApple interdomain linkers (arrows indicate cleavage positions), and 
calculated molecular weights of the substrate and the products are also indicated. 
 
Figure 4. Substrate calibration curves of relative fluorescence intensity units versus 
substrate concentration. Linear regression analysis was used to evaluate results of the 
calibration and determine R2 and slope values. Graphs show the calibration curves of His6-
MBP-VSQNY↓PIVQ-mTurquoise2 (A, B) and His6-MBP-VSQNY↓PIVQ-mApple (C, D) 
substrates in cleavage (A, C) and elution buffers (B, D). 
 
Figure 5. Michaelis–Menten plots of velocity versus substrate concentration. Graphs 
show the results of cleavage of His6-MBP-VSQNY↓PIVQ-mApple (A) and His6-MBP-
VSQNY↓PIVQ-mTurquoise2 (B) substrates by HIV-1 PR. PIVQ-mApple (A) and PIVQ-
mTurquoise2 (B) fluorescent cleavage products were measured by a fluorescence plate reader 
in the supernatants of the cleavage reactions. Non-linear regression analysis was used to 
evaluate the results of the protease assays and determine vmax and Km values. Representative 
time courses are also shown for His6-MBP-VSQNY↓PIVQ-mApple (C) and His6-MBP-
VSQNY↓PIVQ-mTurquoise2 (D) substrates in the case of cleavage by HIV-1 PR. 
Concentrations of PIVQ-mApple (C) and PIVQ-mTurquoise2 (D) fluorescent cleavage 
products have been calculated and plotted against time. 
 
Figure 6. Inhibition of HIV-1 PR by amprenavir. His6-MBP-VSQNY↓PIVQ-mTurquoise2 
fusion protein was used as substrate for inhibition measurement.  
 
Figure 7. Dependence of TEV PR activity on pH. Activity of TEV PR was measured at 
different pH by using His6-MBP-VSQNY↓PIVQ-mTurquoise2 fusion protein as substrate.  
 
Figure 8. Spontaneous dissociation of substrates from the magnetic beads is dependent 
on pH. Spontaneous substrate dissociation from the Ni-NTA agarose bead surface was 
examined in TEV PR pH dependence study by using His6-MBP-VSQNY↓PIVQ-
mTurquoise2 fusion protein as substrate.  
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Table 1. Kinetic parameters of HIV-1 and TEV PRs. A) His6-MBP-VSQNY↓PIVQ-
mTurquoise2 and His6-MBP-VSQNY↓PIVQ-mApple substrates were used for activity 
measurements. Kinetic parameters were determined by non-linear regression of data. B) 
Kinetic parameters determined for the HIV-1 PR using an oligopeptide substrate. 
 
A)     
 
Fluorescent 
protein 
kcat 
(s-1) 
Km  
(mM) 
kcat/Km  
(mM-1 s-1) 
HIV-1 PR 
mTurquoise2 0.321±0.001 0.0163 ± 0.0001 19.69 ± 0.14 
mApple 0.050± 0.0008 0.0027 ± 0.0002 18.52 ± 1.40 
TEV-PR 
mTurquoise2 0.0050 ± 0.0001 0.0024 ± 0.0003 2.08 ± 0.26 
mApple 0.0038 ± 0.0001 0.0021 ± 0.0004 1.81 ± 0.35 
B)     
 oligopeptide kcat (s-1) 
Km  
(mM) 
kcat/Km  
(mM-1 s-1) 
HIV-1 PR VSQNY↓PIVQ 32.21 ± 5.34 2.02 ± 0.51 15.94 ± 4.82 
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